The Marcus Corporation (MCS) is a Milwaukee-based hospitality and entertainment company operating Marcus Theatres and Marcus Hotels & Resorts. It carries meaningful sell-side coverage. Four current, attributable analyst price targets were reviewed to build the central figure: Wedbush at $32 (Outperform, lowered from $34 in early November), Barrington Research at $35 (raised from $33 in late October), B. Riley Securities at $30 (Hold, raised from $29 in mid-October), and StoneX at $33 (raised from $22 in July). I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
These four targets average $32.50, with a low-to-high range of $30 to $35. The overall posture is constructive, though not unanimous: three firms carry Buy or Outperform ratings, while B. Riley’s Hold and $30 target reflect a more cautious view that much of the near-term upside is already reflected. The key reasoning cited by bulls includes a steadier, family-oriented theatrical release slate, hotel results outpacing industry benchmarks, and capital-allocation flexibility, while the more cautious view centers on valuation after a strong run.
With the stock near $25.70, reaching $32.50 implies about 27% upside, a substantial move by any measure. The path is complicated by recent history: MCS has already traded as high as $32.42 over the past 52 weeks before pulling back, meaning the $32.50 target sits essentially at the prior peak rather than far above it. The stock has roughly doubled over the past year, lifting its trailing price-to-earnings (P/E) ratio to around 31-33, with a forward P/E near 29. That re-rating means future gains would likely need to be driven more by earnings growth than by further multiple expansion.
The 52-week range runs from roughly $14.63 to $32.42. The $32.42 level marks durable overhead resistance, essentially coinciding with the $32.50 target. The round $30 figure is an intermediate psychological level. On the downside, the $25 area has acted as a nearby support level following the recent pullback from the high, and a break below it could open the door to lower levels. The long-term trend remains higher after the stock’s powerful advance, but the consolidation below the prior high keeps the near-term structure neutral-to-constructive. From what I see, monitoring these levels closely will be key in the coming weeks.
Analyst price targets typically reflect a roughly 12-month research horizon, and the four targets reviewed here are all recent, spanning late July through early November. Investors should watch quarterly earnings and guidance, box-office and RevPAR trends, any dividend or buyback announcements, analyst target revisions, and consumer-spending data. Wedbush’s target cut from $34 to $32 and Barrington’s increase to $35 show that even bullish analysts disagree on how much of the recovery is already priced in. I’m watching this closely as the earnings season unfolds.
For traders who want more than a quarterly research view, Tickeron’s AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs and generate Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. The platform is designed to help traders discover opportunities, monitor existing positions, and spot shifting trends more efficiently than manual screening allows. Investors evaluating MCS can pair this signal layer with the analyst targets above for a more complete market outlook.
In my own analysis of names like MCS, I often turn to Tickeron’s suite of AI tools to cross-check signals and compare performance across sectors. The AI Daily Buy/Sell Signals platform stands out for its ability to deliver real-time insights that complement traditional analyst targets, helping me stay on top of momentum shifts without spending hours on manual reviews. It has become a regular part of how I evaluate opportunities in the hospitality and entertainment space.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Financial analyst and market blogger with expertise in equity research, fundamental analysis, and macroeconomic trends. I regularly publish coverage on individual stocks, ETFs, and sector developments — combining rigorous financial analysis with clear, engaging writing for a broad investment audience.
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where MCS declined for three days, in 195 of 303 cases, the price declined further within the following month. The odds of a continued downward trend are 64%.
The Momentum Indicator moved below the 0 level on November 17, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MCS as a result. In 46 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 60%.
The Moving Average Convergence Divergence Histogram (MACD) for MCS turned negative on October 30, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In 20 of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at 56%.
MCS moved below its 50-day moving average on November 05, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for MCS crossed bearishly below the 50-day moving average on November 03, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 9 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 45%.
The RSI Indicator entered the oversold zone -- be on the watch for MCS's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +1.52% 3-day Advance, the price is estimated to grow further. Considering data from situations where MCS advanced for three days, in 195 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.
MCS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron Price Growth Rating for this company is 40 (best 1 - 100 worst), indicating steady price growth. MCS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is 49 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 76, placing this stock slightly better than average.
The Tickeron Valuation Rating of 59 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.806) is normal, around the industry mean (12.927). P/E Ratio (35.680) is within average values for comparable stocks, (38.855). Projected Growth (PEG Ratio) (2.499) is also within normal values, averaging (2.430). Dividend Yield (0.013) settles around the average of (0.048) among similar stocks. P/S Ratio (1.082) is also within normal values, averaging (2.898).
The Tickeron SMR rating for this company is 83 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 88 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
an operator of hotels, resorts and movie theaters
Industry MoviesEntertainment